2023
DOI: 10.1016/j.jval.2023.03.562
|View full text |Cite
|
Sign up to set email alerts
|

EE261 Cost-Effectiveness of Adding Darolutamide to Docetaxel and Androgen Deprivation Therapy in the Treatment of Metastatic Hormone-Sensitive Prostrate Cancer

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles